14 episodes

Blood cancers are complex and multifaceted diseases, requiring knowledge by healthcare professionals on the array of diagnostic tests, treatment therapies, and survivorship issues. The LLS Podcast Series for Professionals provides up to date and accurate information on diagnosis, treatment and survivorship to educate HCPs treating patients with blood cancer. Listen in as we speak with experts who will guide us in understanding these topics, as well as address the importance of clinical trials, side effects management, and other concerns.

Treating Blood Cancers The Leukemia & Lymphoma Society

    • Science

Blood cancers are complex and multifaceted diseases, requiring knowledge by healthcare professionals on the array of diagnostic tests, treatment therapies, and survivorship issues. The LLS Podcast Series for Professionals provides up to date and accurate information on diagnosis, treatment and survivorship to educate HCPs treating patients with blood cancer. Listen in as we speak with experts who will guide us in understanding these topics, as well as address the importance of clinical trials, side effects management, and other concerns.

    Mantle Cell Lymphoma: Disease and Treatment Updates

    Mantle Cell Lymphoma: Disease and Treatment Updates

    Anita Kumar, MD, Memorial Sloan Kettering Cancer Center, Basking Ridge, NJ















    Recorded on November 11, 2019





    What is mantle cell lymphoma (MCL)? How is it diagnosed? How does it differ from chronic lymphocytic leukemia? In this episode, Dr. Anita Kumar of Memorial Sloan Kettering Cancer Center breaks down the biology of the disease, addresses new and emerging treatment options, and discusses approaches to both indolent and aggressive MCL. Tune in for a comprehensive understanding of MCL today!

    Anita Kumar, MD

    Medical Oncologist

    Memorial Sloan Kettering Cancer CenterBasking Ridge, NJ

    • 29 min
    Treatment Considerations for NHL as a Chronic Disease

    Treatment Considerations for NHL as a Chronic Disease

    Susan McCall, MSN, ANP-BC, AOCNP®, Memorial Sloan Kettering Cancer Center, New York, NY















    Recorded on September 18, 2019





    How do healthcare professionals communicate with patients about the issues related to living with a chronic disease? In this episode, Susan McCall, ANP-BC, AOCNP®, a nurse practitioner at Memorial Sloan Kettering Cancer Center in New York, discusses her role in educating patients and their caregivers on living with non-Hodgkin lymphoma, treatment, including clinical trials, financial and fertility concerns, psychosocial considerations, and more. Tune in today!

    Susan J. McCall, MSN, ANP-BC, AOCNP®

    Clinical Trials Nurse Practitioner

    Lymphoma Service

    Memorial Sloan Kettering Cancer Center

    New York, NY

    • 31 min
    CAR T-cell Therapy: The Nurse’s Role in Treating Patients

    CAR T-cell Therapy: The Nurse’s Role in Treating Patients

    Elizabeth A. Weber, BSN, RN, Heather DiFilippo, MSN, CRNP and Erin Medoff, RN, MSN, APRN















    Recorded live at The Leukemia & Lymphoma Society’s Symposium on CAR T-cell Therapy on June 28, 2019





    In this episode, we are joined by three nurses to discuss their important and varied roles in treating patients with CAR T-cell therapy: Elizabeth Weber, who serves as a logistical nurse navigator, and Heather DiFilippo and Erin Medoff, both advanced practice nurses. Our guests discuss the importance of the continuity of care nurses provide, their role in educating patients and families about CAR T therapy, how to navigate this process, and much more. Tune in today!

























    Elizabeth A. Weber, BSN, RNCommercial Cellular Therapy CoordinatorUniversity of Pennsylvania Health SystemPhiladelphia, PA



    Heather DiFilippo, MSN, CRNPCertified Adult Nurse PractitionerUniversity of Pennsylvania Health SystemPhiladelphia, PA





    Erin Medoff, RN, MSN, APRNOncology Nurse PractitionerMalignant HematologyYale New Haven HospitalNew Haven, CTAssistant Clinical ProfessorYale University School of NursingOrange, CT

    • 40 min
    A Discussion on the Future of CAR T-cell Therapy with Dr. Frederick Locke

    A Discussion on the Future of CAR T-cell Therapy with Dr. Frederick Locke

    Frederick L. Locke, MD, Moffitt Cancer Center, Tampa, FL















    Recorded on September 3, 2019





    Join Dr. Miller as he speaks with Dr. Frederick Locke from Moffitt Cancer Center in Tampa, FL on the future of CAR T-cell therapy. In this episode, Dr. Locke discusses new indications for treatment, including off-the-shelf CAR T-cells, earlier lines of therapy, allogeneic treatment options, the necessity for preparative regimens, suicide genes, dual antigen binding, and so much more. Listen in today!

    Frederick L. Locke, MD

    Vice-Chair

    Research Director and Medical Director, Immune Cell Therapy Program

    Department of Blood and Marrow Transplant and Cellular Immunotherapy

    Co-Leader Immunology Program

    Moffitt Cancer Center

    Tampa, FL









    This podcast episode is supported by Allogene Therapeutics, Inc.

    • 30 min
    CAR T-cell Therapy: A Deeper Dive into Adverse Effects and Financial Toxicities

    CAR T-cell Therapy: A Deeper Dive into Adverse Effects and Financial Toxicities

    Sergio Giralt, MD, Memorial Sloan Kettering Cancer Center and Gunjan Shah, MD, Memorial Sloan Kettering Cancer Center















    Recorded live at The Leukemia & Lymphoma Society’s Symposium on CAR T-cell Therapy on June 28, 2019





    Tune in as Dr. Sergio Giralt and Dr. Gunjan Shah, hematologist-oncologists at Memorial Sloan Kettering Cancer Center in New York, discuss adverse effects and financial toxicities associated with chimeric antigen receptor (CAR) T-cell therapy. In this episode, Dr. Giralt discusses how cytokine release syndrome (CRS), neurotoxicities, and other side effects affect patients receiving CART therapy, and Dr. Shah reviews the challenges associated with the high cost of treatment and care.















    Sergio Giralt, MD

    Chief Attending

    Adult Bone Marrow Transplant Service

    Memorial Sloan Kettering Cancer Center

    New York, NY



    Gunjan Shah, MD

    Adult Bone Marrow Transplant Servicefor Health Policy & OutcomesMemorial Sloan Kettering Cancer Center

    New York, NY

    • 33 min
    CAR T-cell Therapy: A 60,000 Foot View

    CAR T-cell Therapy: A 60,000 Foot View

    Dennis Cooper, MD, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ















    Recorded live at The Leukemia & Lymphoma Society’s Symposium on CAR T-cell Therapy on June 28, 2019





    What is CAR T-cell therapy? Listen in as Dr. Dennis Cooper, Professor of Medicine and Chief of the Bone Marrow Transplant Service at Rutgers Cancer Institute of New Jersey, reviews the principles of CAR T-cell therapy, discusses the treatment process and efficacy, and highlights future advances.











    Dennis Cooper, MD

    Chief, Blood and Marrow Transplantation

    Medical Oncologist

    Rutgers Cancer Institute of New Jersey

    New Brunswick, NJ

    • 18 min

Top Podcasts In Science

Listeners Also Subscribed To